Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases

Archives of Surgery

Volumn 146, Issue 4, 2011, Pages 471-478

  Neal, Christopher P ^a   Mann, Christopher D ^a   Garcea, Giuseppe ^a   Briggs, Christopher D ^a   Dennison, Ashley R ^a   Berry, David P ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

ADULT; AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GREAT BRITAIN; HEPATECTOMY; HUMANS; INFECTION; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 79955048993     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2011.50     Document Type: Article

References (40)

1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg. 1999;230(3):309-321. (Pubitemid 30191861)
2. Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246(5):806-814. (Pubitemid 350035657)
3. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies. Br J Cancer. 2006;94(7):982-999.
4. Laurent C, Sa Cunha A, Couderc P, Rullier E, Saric J. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg. 2003;90(9):1131-1136. (Pubitemid 37152173)
5. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients. Ann Surg. 2008;247(1):125-135.
6. Virani S, Michaelson JS, Hutter MM, et al. Morbidity and mortality after liver resection: Results of the patient safety in surgery study. J Am Coll Surg. 2007; 204(6):1284-1292. (Pubitemid 46819089)
7. Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Complications and costs after high-risk surgery: Where should we focus quality improvement initiatives? J Am Coll Surg. 2003;196(5):671-678. (Pubitemid 36560195)
8. Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ; Participants in the VA National Surgical Quality Improvement Program. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242(3):326-343. (Pubitemid 41306597)
9. Rizk NP, Bach PB, Schrag D, et al. The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. J Am Coll Surg. 2004;198(1):42-50. (Pubitemid 38201087)
10. Law WL, Choi HK, Lee YM, Ho JW. The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol. 2007;14(9):2559-2566. (Pubitemid 47389572)
11. McArdle CS, McMillan DC, Hole DJ. Impact of anastomotic leakage on longterm survival of patients undergoing curative resection for colorectal cancer. Br J Surg. 2005;92(9):1150-1154. (Pubitemid 41284881)
12. Ito H, Are C, Gonen M, et al. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg. 2008; 247(6):994-1002. (Pubitemid 351770420)
13. Schiesser M, Chen JW, Maddern GJ, Padbury RT. Perioperative morbidity affects long-term survival in patients following liver resection for colorectal metastases. J Gastrointest Surg. 2008;12(6):1054-1060.
14. Farid SG, Aldouri A, Morris-Stiff G, et al. Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg. 2010;251(1):91-100.
15. O'Riordain MG, Falconer JS, Maingay J, Feaorn KC, Ross JA. Peripheral blood cells from weight-losing cancer patients control the hepatic acute phase response by a primarily interleukin-6 dependent mechanism. Int J Oncol. 1999; 15(4):823-827.
16. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448-454. (Pubitemid 29084777)
17. Crumley AB, McMillan DC, McKernan M, Going JJ, Shearer CJ, Stuart RC. An elevated C-reactive protein concentration, prior to surgery, predicts poor cancerspecific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer. 2006;94(11):1568-1571. (Pubitemid 43924914)
18. Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6 (1):149-163.
19. Leitch EF, Chakrabarti M, Crozier JE, et al. Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer. 2007;97(9):1266-1270. (Pubitemid 350035815)
20. Neal CP, Mann CD, Sutton CD, et al. Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases. Eur J Cancer. 2009;45(1):56-64.
21. Halazun KJ, Aldoori A, Malik HZ, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol. 2008;34(1):55-60. (Pubitemid 350296756)
22. Wong VK, Malik HZ, Hamady ZZ, et al. C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer. 2007;96(2):222-225. (Pubitemid 46160625)
23. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-867. (Pubitemid 36019639)
24. Yang J, Wezeman M, Zhang X, et al. Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell. 2007;12(3):252-265. (Pubitemid 47333419)
25. Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC. Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer. 2009;100(8):1236-1239.
26. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-213. (Pubitemid 38963009)
27. Ferrero A, Lo Tesoriere R, Viganó L, Caggiano L, Sgotto E, Capussotti L. Preoperative biliary drainage increases infectious complications after hepatectomy for proximal bile duct tumor obstruction. World J Surg. 2009;33(2):318-325.
28. Bone RC, Balk RA, Cerra FB, et al; The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644-1655.
29. Vauthey JN, Pawlik TM, Abdalla EK, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg. 2004;239(5):722-732. (Pubitemid 38525644)
30. Donskov F, von der Maase H. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol. 2006;24(13):1997- 2005. (Pubitemid 46622107)
31. Pang YY. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2002;4(2):99-100.
32. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: Analysis of 1,803 consecutive cases over the past decade. Ann Surg. 2002;236(4):397-407.
33. Canna K, McArdle PA, McMillan DC, et al. The relationship between tumour Tlymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer. 2005; 92(4):651-654. (Pubitemid 40460599)
34. Du Clos TW, Mold C. C-reactive protein: An activator of innate immunity and a modulator of adaptive immunity. Immunol Res. 2004;30(3):261-277. (Pubitemid 39546229)
35. Szabo G, Kodys K, Miller-Graziano CL. Elevated monocyte interleukin-6 (IL-6) production in immunosuppressed trauma patients, I: Role of Fc- RI crosslinking stimulation. J Clin Immunol. 1991;11(6):326-335.
36. Lundy J, Ford CM. Surgery, trauma and immune suppression: Evolving the mechanism. Ann Surg. 1983;197(4):434-438. (Pubitemid 13112785)
37. Mynster T, Christensen IJ, Moesgaard F, Nielsen HJ; Danish RANX05 Colorectal Cancer Study Group. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg. 2000;87(11): 1553-1562.
38. Panis Y, Ribeiro J, Chrétien Y, Nordlinger B. Dormant liver metastases: An experimental study. Br J Surg. 1992;79(3):221-223.
39. Crozier JE, McKee RF, McArdle CS, et al. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg. 2007;94(8):1028-1032. (Pubitemid 47236550)
40. Balkwill F, Mantovani A. Cancer and inflammation: Implications for pharmacology and therapeutics. Clin Pharmacol Ther. 2010;87(4):401-406.